Optical Hemodynamic Imaging of Jugular Venous Dynamics During Altered
  Central Venous Pressure by Amelard, Robert et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. XX, NO. XX, XXXXXX 1
Optical Hemodynamic Imaging of Jugular Venous
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Robert Amelard, Member, IEEE, Andrew D Robertson, Courtney A Patterson, Hannah Heigold, Essi Saarikoski,
Richard L Hughson
Abstract—Objective: An optical imaging system is proposed
for quantitatively assessing jugular venous response to altered
central venous pressure. Methods: The proposed system assesses
sub-surface optical absorption changes from jugular venous
waveforms with a spatial calibration procedure to normalize
incident tissue illumination. Widefield frames of the right lateral
neck were captured and calibrated using a novel flexible surface
calibration method. Jugular venous optical attenuation (JVA)
signals were computed using an optical model for quantifying
hemodynamic changes, and a jugular venous pulsatility map
was computed using a time-synchronized arterial waveform.
JVA was assessed in three cardiovascular protocols that altered
central venous pressure by inducing acute central hypovolemia
(lower body negative pressure), venous congestion (head-down
tilt), and impaired cardiac filling (Valsalva maneuver). Results:
JVA waveforms exhibited biphasic properties and sub-wave
timing consistent with jugular venous pulse dynamics with time-
synchronized electrocardiogram waves. JVA correlated strongly
(median, interquartile range) with invasive central venous pres-
sure during graded central hypovolemia (r=0.85, [0.72, 0.95]),
graded venous congestion (r=0.94, [0.84, 0.99]), and impaired
cardiac filling (r=0.94, [0.85, 0.99]). Reduced JVA during graded
acute hypovolemia was strongly correlated with reductions in
stroke volume (SV) (r=0.85, [0.76, 0.92]) from baseline (SV:
79 ± 15 mL, JVA: 0.56 ± 0.10 a.u.) to −40 mmHg suction
(SV: 59 ± 18 mL, JVA: 0.47 ± 0.05 a.u.; p<0.01). Conclusion:
The proposed non-contact optical imaging system demonstrated
jugular venous dynamics consistent with invasive central venous
monitoring during three protocols that altered central venous
pressure. Significance: This system provides non-invasive mon-
itoring of pressure-induced jugular venous dynamics in clini-
cally relevant conditions where catheterization is traditionally
required, enabling monitoring in non-surgical environments.
Index Terms—Optical imaging, near-infrared, Beer-Lambert,
photoplethysmography, central venous pressure, jugular vein.
I. INTRODUCTION
The cardiovascular system is a closed-loop system in which
cardiac output and venous return remain in balance under
state-steady conditions. Adequate venous return is essential to
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maintain cardiac output and regulate arterial blood pressure.
Venous return is largely determined by the pressure gradient
between the systemic veins and the right atrium [1]. Due to
the high compliance of veins, venous blood volumes provide
pressure-related fluid biomarkers of cardiac, systemic, and
cerebrovascular regulation [2], [3].
Central venous pressure (CVP) is a major determinant of
cardiac filling pressures and preload. Elevated jugular venous
pressure (JVP) is a primary indicator of congestion in heart
failure [4]. Heart failure and other diseases that restrict venous
drainage, such as jugular vein thrombosis, are primary causes
of intracranial hypertension and papilledema [5], [6]. Head-
down tilt (HDT), a model for spaceflight microgravity and
venous stagnation [7], has demonstrated chronically elevated
intracranial pressure above seated levels on Earth over 24 h [8],
and recent investigations found venous thrombosis and stag-
nation/retrograde flow in astronauts during spaceflight [9].
In contrast, hypovolemic states, such as acute blood loss,
induce arterial pressure changes secondary to reduced cardiac
filling with lower CVP [10]. Monitoring changes in CVP
may provide important biomarkers relevant to cardiac and
cerebral function; however, this measurement is not routinely
performed due to invasive surgical right heart catheterization
required to assess these pressure changes.
Due to its proximity to the heart, the jugular vein hemo-
dynamics closely reflect those of CVP in many conditions.
Elevated JVP is a biomarker of congestive heart failure, and
provides insight into patient fluid status and response to diure-
sis [11], [12]. Clinically, jugular venous assessment is a visual
task prone to inter-rater reliability errors [13]. Ultrasound
has been used to quantify jugular distension for evaluating
heart failure and right atrial pressure [14], [15], but is not
suitable for longitudinal continuous monitoring. Mobile health
devices capable of tracking JVP may enable breakthrough
heart failure management beyond patient-reported functional
and physiological data [16].
There has been recent interest in non-invasive and non-
contact optical jugular venous monitoring. Skin surface dis-
placement assessment from video [17], [18], [19] can en-
hance jugular venous pulse identification, but does not con-
tain information related to jugular distension. Other methods
have been derived from non-contact photoplethysmographic
imaging systems that traditionally monitor arterial hemody-
namics [20]. Photon migration properties of near-infrared
light enable deeper tissue penetration than superficial visible
spectrum light [21]. Thus, optical systems have been investi-
gated to assess the JVP waveform using variations in optical
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Fig. 1: Diagram of the optical imaging instrumentation. LED
illumination (940 nm) was passed through a condenser lens
(L1), spatial homogenizer (L2), and linear polarizer (P1).
Reflected light was cross polarized (P2) and near-infrared
bandpass filtered (F1) prior to being imaged by the camera.
absorption resulting from hemodynamic fluctuations in blood
volume [22], [23]. Since pressure changes induce jugular
distension and relaxation, optical approaches are promising
for quantifying changes in CVP.
In this paper, we propose an optical imaging system to as-
sess jugular venous dynamics associated with altered CVP. The
main contributions of this work are: (1) an optical model for
quantifying optical changes related to hemodynamic processes
(i.e., vessel pulsatility), (2) a novel surface calibration method
that forms to curved surfaces of the neck, and (3) an image
processing pipeline for denoising and identifying the jugular
venous pulse spatial distribution. The calibration procedure
enables monitoring dynamic venous changes within an indi-
vidual by normalizing tissue reflectance with varying camera-
tissue geometry. We designed a cardiovascular protocol that
modified CVP in three deterministic ways by controlling
pressure gradients along the body: (1) reduced venous return
from acute central hypovolemia through graded lower body
negative pressure (LBNP); (2) increased CVP and venous
congestion through head-down tilt (HDT); and (3) impaired
cardiac filling from increased intrathoracic pressure through a
guided Valsalva maneuver. Taken together, this protocol eval-
uated system response across clinically and physiologically
relevant perturbations by simulating effects of hemorrhagic
trauma, venous congestion, and heart failure.
II. JUGULAR OPTICAL IMAGING
A. Instrumentation
Fig. 1 depicts the optical imaging setup. The tissue was
illuminated with a 940 nm LED (LZ1-10R702, LEDEngin)
for increased tissue penetration due to low melanin absorption,
epidermal and dermal scattering, and hemoglobin absorp-
tion [21], thus increasing the probability of photons returning
to the surface after penetrating the vessel. A uniform beam
profile was attained through a mounted diffused spot beam lens
optic and custom Fly’s eye condenser, and polarized with a
linear polarizer. These components were contained in a custom
tube assembly and mounted in the same plane as the camera,
beneath the camera lens. Tissue reflection was cross-polarized
to reduce surface-level specular reflection, and near-infrared
bandpass filtered prior to being imaged by the camera (GS3-
U3-41C6NIR-C, FLIR).
B. Optical Model
For bulk homogeneous tissue, light attenuation (or optical
density) can be calculated by the modified Beer-Lambert
law [24]:
A = − log
(
I
I0
)
=
∑
i
µa,iL+G (1)
where A is attenuation, I and I0 are the detected and
incident illumination, µa = log(10)εici is the absorption
coefficient of chromophore i based on its molar extinction
coefficient (εi) and concentration (ci), L is the photon mean
path length through the tissue, and G is an intensity loss
term due to scatter. With pulsatile flow, we are interested
in modeling the temporal dynamics of light attenuation due
to changes in blood volume (vessel diameter). A standard
approach in continuous wave near-infrared spectroscopy is to
use the attenuation differential with multiple wavelengths to
estimate changes in hemoglobin concentrations [25]. However,
when considering pulsatile vessels in unchanging tissue, it
is primarily the photon path length that changes with vessel
expansion/contraction [26]. Thus, expressing Eq. (1) in terms
of time in this pulsatile model yields:
A(t) = − log
(
I(t)
I0
)
= µa,tLt + µa,vLv(t) +G (2)
where µa,t and µa,v are the absorption coefficients for the
surrounding tissue and vessel, respectively, similarly for Lt
and Lv . We can further expand the vessel absorption:
µa,v = αµa,HbO2 + (1− α)µa,Hb (3)
where α is the blood oxygen saturation in the vessel. Express-
ing attenuation in terms of temporal differences yields:
∆A = − log
(
I(t2)
I(t1)
)
= µa,v(Lv(t2)− Lv(t1)) (4)
Thus, assuming constant oxygen saturation in the vessel (con-
stant α), and that changes in the bulk tissue properties are
small compared to changes in vessel absorption, changes in
measured attenuation are linearly proportional to changes in
mean photon path length through the vessel resulting from
changes in vessel diameter.
C. Imaging Calibration
The formulation of Eq. (4) only holds if I0 is constant across
the differential measurements. Changes in tissue-imaging ori-
entation cause differences in illumination profiles, making
cross-condition comparison unreliable, since I0 becomes a
function of camera-tissue orientation. To compensate for this
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Fig. 2: Overview of the jugular optical imaging system. Frames were captured of the right lateral area of the neck. Reflectance
was calibrated using a custom flexible diffuse calibration target. Attenuation frames were computed from motion corrected and
denoised reflectance frames, and used with the finger arterial waveform to generate a venous pulsatility map for jugular pulse
waveform extraction.
effect, the imaging field was calibrated prior to each ac-
quisition by deriving the spatial frequency domain imaging
calibration with uniform planar illumination (fx = 0) [27]:
Rd(xi) =
Mtissue(xi)
Mref (xi)
Rˆd,ref (xi) (5)
M(xi) = I0(xi) · MTFsystem(xi) ·Rd(xi) (6)
where Rd(xi) is the diffuse reflectance at location xi, I0 is
the source intensity, MTFsystem is the modulation transfer
function of the optical system, and Rˆd,ref is the predicted
reflectance profile of the calibration target. The calibration
target must be thin and conform to the profile of the tissue
for the incident illumination terms to cancel each other out.
Under these conditions, this calibration corrects for surface
profilometry and illumination inhomogeneities.
Fig. 2 depicts the processing pipeline for extracting jugular
waveforms from a set of optical images. Reference images
were acquired using a custom flexible calibration target that
was wrapped around the participant’s neck such that it fol-
lowed the contour of the tissue. The calibration target was
constructed from a 1/16 in white nitrile rubber sheet. Its strong
scattering properties resulted in minimal transmittance and
maximal reflectance, ensuring consistent spatial and temporal
properties that are unaffected by underlying tissue. The mate-
rial’s resilience at thin profiles allowed it to conform to the tis-
sue profile. Two thousand grit sandpaper was used to produce
a highly diffuse uniform reflectance profile, approximating
a Lambertian surface. The predicted calibration reflectance
profile Rˆd,ref was therefore modeled as a uniform distribution
at unity. Calibration geometry was designed to conform to the
participant’s neck with no gap between the tissue and target,
extending from the clavicle to the mandible with good lateral
coverage. Three sizes of the calibration target were developed
to account for anthropometric differences across participants.
The calibration target was secured to the tissue using surgical
tape, which was applied to the back of the calibration target
outside the imaging area of interest. A calibration image was
obtained before every acquisition by averaging 120 frames of
the calibration target wrapped around the participant’s neck.
D. Venous Pulsatility Map
Prior to attenuation calculation, each diffuse reflectance
signal Rd(xi) was down-sampled using a 4x4 mean filter
to increase signal-to-noise ratio, and then denoised using a
hemodynamic Kalman filter formulation [28]. This temporal
domain filter has been shown to preserve waveform shape
and feature timings by incorporating system specific noise
models into a linear state estimation system conditioned on
previous states. Briefly, the system state at each time point k
was defined according to the signal measurement and rate of
change, and the denoised signal was estimated using a smooth
continuous vessel wall motion prior:
sk =
[
sk
s˙k
]
=
[
1 ∆t
0 1
]
sk−1 (7)
where sk and s˙k are the signal amplitude and rate of change
of the amplitude. The measurement noise model was charac-
terized by the pixel standard deviation across the sensor in a
dark field, and the process noise model was computed using
a logarithmic grid search for optimal hemodynamic fit. The
denoised diffuse reflectance signal was extracted at each time
point using an observation matrix on the estimated state:
Rˆd(xi, tk) = H sˆk (8)
where H = [1 0]T . Finally, the calibrated attenuation for cross-
condition comparison was calculated for each location in each
frame:
A(xi, tk) = − log(Rˆd(xi, tk)) (9)
Contraction-relaxation asynchrony between the atria and
ventricles creates pressure waveforms in the jugular venous
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and arterial circulations that are out of phase [23]. Thus, to
localize the jugular venous pulse, a spatial correlation filter
was performed against a time-synchronized finger arterial
waveform [29]. Specifically, correlation between attenuation
signals and the arterial waveform was computed for each tissue
location xi, producing a venous pulsatility map:
V (xi) = r(A(xi), z) · 1R− (r(A(xi), z)) (10)
where r(A(xi), z) is the linear correlation between attenuation
signals and the arterial waveform, and 1R− is the indicator
function of negative real numbers. Thus, signals that are
negatively correlated with the arterial waveform (i.e., out of
phase) were identified, along with their associated correlation
strength.
III. DATA COLLECTION AND EXPERIMENTAL DESIGN
A. Participants
Twenty young healthy adults (10 female, 24 ± 4 years,
169 ± 11 cm, 66 ± 13 kg) with no history of vascular, in-
flammatory, or thrombotic disease were enrolled. Participants
abstained from caffeine, nicotine, alcohol, and heavy exercise
for 24 h prior to testing and were fasted for 2 h prior to
testing. Participants were asked to consume 2 L of water 2 h
prior to testing to ensure a hydrated state. One participant’s
data were removed due to an insufficient area for imaging,
and another participant’s LBNP data were removed due to
acquisition issues. The study was approved by a University
of Waterloo Research Ethics Committee (ORE #40394) and
all protocols conformed to the Declaration of Helsinki. All
participants provided written informed consent prior to testing.
B. Experimental Protocol
Participants were instrumented with an electrocardiogram
(iE33 xMatrix, Philips Healthcare, Andover, USA), contin-
uous arterial blood pressure plethysmogram with estimated
stroke volume (SV) via Modelflow (NOVA, Finapres Medical
Systems, Enschede , NL), a nasal cannula connected to a
capnograph for end-tidal carbon dioxide (PETCO2; CD-3A
CO2 Analyzer, AMETEK Inc., Pittsburgh, PA, USA), and a
respiratory belt (Model 0528, Respiratory Effort PVDF Sensor,
Braebon, NY, USA). Continuous CVP was measured using a
catheter placed in a vein in the right antecubital fossa [30]. The
vein was punctured using a single-use 20G needle and attached
to a pressure monitoring transducer through a saline-filled
polyurethane catheter. The pressure transducer was positioned
at the level of the right midclavicular line using a laser level to
estimate the level of the right heart and manually calibrated at
0, 5, 10, and 15 cmH2O. Participants were tilted to the right to
ensure a continuous column of fluid between the right atrium
and an antecubital vein. LBNP and Valsalva pressures were
monitored using a digital manometer. The imaging head was
positioned such that it provided orthogonal illumination [31]
to the right lateral area of the neck. The system was moved
with the participant between conditions to maintain a similar
field of view and angle of illumination.
Data were recorded at 1000 Hz (PowerLab, LabChart,
version 7.3.7; ADInstruments, Colorado Springs, CO). Hemo-
dynamic frames were captured in uncompressed video format
at 60 fps with 16 ms exposure time, and a finger pho-
toplethysmography probe was transmitted concurrently with
video frames at 100 Hz and down-sampled to 60 Hz to match
the video frame rate. A hardware trigger was transmitted
to PowerLab to synchronize the cardiovascular and imaging
acquisitions.
Three maneuvers were performed that systematically
changed CVP dynamics: LBNP (reduced venous return from
central hypovolemia), HDT (venous congestion through cepha-
lad fluid shift [32], [33]), and Valsalva maneuver (impaired
cardiac filling from increased intrathoracic pressure). All par-
ticipants underwent three HDT conditions (0, −3, and −6 °)
and four LBNP conditions (0, −20, −30, and −40 mmHg),
with randomized ordering of the two protocols. Approximately
5 min was spent in each condition. A calibration and 30 s video
were acquired during the last minute of each condition. LBNP
was terminated if systolic blood pressure fell below 70 mmHg
at any point during the collection. HDT and LBNP protocols
were separated by at least 5-minutes of supine rest. Participants
then voluntarily completed a 15 s Valsalva maneuver to a
pressure of 40 mmHg (or the participant’s maximum attainable
pressure) while breathing into a mouthpiece, with one practice
maneuver prior to collection. Data were recorded during the
Valsalva, as well as 15 s before (baseline) and after (recovery).
To compensate for participant movement during the Valsalva,
frames were registered by tracking a salient feature on the
neck using a linear dual correlation filter [34].
C. Data Analysis
Data were analyzed in LabChart (ADInstruments Inc., Col-
orado, USA) using beat-by-beat averages calculated over the
same 30 s period in which imaging occurred. Baseline and
recovery measures during the Valsalva protocol were extracted
as 10 s averages starting at the beginning of the protocol and
5 s after the Valsalva maneuver was stopped, respectively.
The peak measure during the Valsalva protocol corresponded
with the CVP apex. The jugular vein was identified by a
contiguous negative correlation segment on the right lateral
area of the neck in the baseline frames. For each participant, a
jugular venous waveform was extracted for each 30 s condition
acquisition in the same area in the center of the vessel track, of
approximately 1 cm long, identified by a strongly negatively
correlated cohesive area close to the clavicle.
Main effects of protocol condition (HDT angle, LBNP
pressure level, Valsalva stage) were determined by one-way
repeated measures ANOVA followed by planned contrasts
between condition to baseline using paired sample t-test when
significant main effects were observed. Significant differences
were reported at p < 0.05 with Bonferroni multiple compari-
son correction. Pearson correlation coefficients were computed
to investigate linear relationships between normalized changes
in JVA, CVP and SV. Data are presented as mean ± SD.
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TABLE I: CARDIOVASCULAR RESPONSE TO THREE TYPES OF CARDIOVASCULAR STRESS
HR
bpm
SV
mL
MAP
mmHg
CVP
cmH2O
JVA
a.u.
Lower body
negative pressure
(mmHg)
0 60 ± 7 79 ± 15 80 ± 9 11.2 ± 3.5 0.56 ± 0.10
−20 64 ± 9* 70 ± 17* 81 ± 11 7.0 ± 3.9* 0.51 ± 0.08*
−30 68 ± 10* 64 ± 18* 82 ± 9 6.5 ± 3.9* 0.50 ± 0.07*
−40 75 ± 13* 59 ± 18* 85 ± 9 6.3 ± 5.0* 0.47 ± 0.05*
Head-down tilt
(tilt angle)
0° 62 ± 8 81 ± 16 80 ± 9 11.6 ± 4.5 0.55 ± 0.09
−3° 61 ± 9 82 ± 15 81 ± 9 13.8 ± 4.6* 0.58 ± 0.10*
−6° 62 ± 9 80 ± 15 80 ± 11 16.4 ± 4.6* 0.61 ± 0.10*
Valsalva
baseline 67 ± 11 84 ± 20 91 ± 8 11.7 ± 4.3 0.71 ± 0.23
peak 85 ± 16* 43 ± 19* 96 ± 13 29.0 ± 11.6* 0.78 ± 0.22*
recovery 64 ± 7 83 ± 19 99 ± 11* 13.1 ± 3.3* 0.74 ± 0.23*
Values (mean ± SD) were averaged across the 30 s video acquisition in lower body negative pressure and head-
down tilt. Valsalva values show 10 s average 5 s before (baseline) and after (recovery) the maneuver, and during
maximal CVP (peak). HR: heart rate; SV: stroke volume; MAP: mean arterial pressure; CVP: central venous
pressure; JVA: jugular venous optical attenuation (calibrated). *p<0.05 compared to baseline (paired sample t-
test)
Fig. 3: Individual and averaged jugular venous waveforms for
each participant while supine, normalized to the cardiac cycle.
The start of each signal was time aligned to the ECG R wave.
IV. RESULTS
A. Jugular Venous Attenuation Signal Extraction
Fig. 3 shows per-participant average and individual JVA
waveforms during supine baseline. Each signal’s start time
was set to the ECG R wave, and expressed as a fraction of
the cardiac cycle. The biphasic nature and primary subwaves
(a, c, x, v, y) of the JVP were visually apparent across
participant waveforms. Recognizing the start time as the peak
of the R wave (ventricular depolarization), the following pulse
wave characteristics were observed: a small rise in pressure
during early systole (c wave); a downstroke following the R
wave during ventricular contraction from right atrial relaxation
and tricuspid valve closure (x wave); an inflection point
approximately half way through the cardiac cycle consistent
with right atrial filling (v wave) and tricuspid valve opening
(y wave); and an upstroke preceding the R wave during atrial
contraction (a wave).
B. Acute Central Hypovolemia
Acute central hypovolemia through graded LBNP resulted
in progressively reduced venous return and, accordingly, SV
(Fig. 4). Significant main effects were observed in heart
rate, SV, CVP, and JVA (Table I). Heart rate was elevated
and SV was depressed during all LBNP levels compared to
baseline. These changes in SV are indicative of decreased
cardiac filling pressures due to the translocation of blood to
the lower extremities. This was corroborated by CVP, which
decreased significantly from baseline (11.2±3.5 cmH2O),
with the largest decreases occurring on initial −20 mmHg
LBNP (7.0±3.9 cmH2O) followed by smaller absolute de-
creases in −30 mmHg (6.5±3.9 cmH2O) and −40 mmHg
(6.3±5.0 cmH2O) LBNP. A similar pattern of JVA changes
was observed, with significant decreases in all grades com-
pared to baseline (0.56±0.10 a.u.), the largest occurring upon
LBNP onset (0.51±0.08 a.u.) followed by smaller absolute
decreases in −30 mmHg (0.50±0.07 a.u.) and −40 mmHg
(0.47±0.05 a.u.). JVA exhibited strong positive linear correla-
tion (median, interquartile range) to CVP (r=0.85, [0.72, 0.95])
and SV (r=0.85, [0.76, 0.92]) during LBNP.
C. Venous Congestion
HDT induced a cephalad fluid shift through hydrostatic
pressure gradient toward the head, resulting in increased ve-
nous pressure (Fig. 4). There were no significant main effects
of central cardiovascular variables (heart rate, SV, MAP) with
increased HDT compared to supine baseline (see Table I).
Significant main effects were observed in CVP and JVA.
CVP increased significantly from baseline (11.6±4.5 cmH2O)
during −3° (13.8±4.6 cmH2O) and −6° (16.4±4.6 cmH2O)
HDT, with a concomitant significant increase in JVA from
supine (0.55±0.09 a.u.) to −3° (0.58±0.10 a.u.) and −6°
(0.61±0.10 a.u.) HDT, signifying increased optical absorption
with pressure-induced venous dilation. JVA exhibited strong
positive linear correlation (median, interquartile range) to CVP
during HDT (r=0.94, [0.84, 0.99]).
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Fig. 4: Change in jugular venous attenuation (JVA) compared
to central venous pressure (CVP) during (a) head-down tilt,
(b) Valsalva, as well as (c) CVP and (d) stroke volume (SV)
during lower-body negative pressure. Data are expressed as
changes relative to the participant’s baseline supine measures.
Error bars indicate 95% confidence intervals. See Table I for
statistical comparisons.
Fig. 5: Representative example the dynamics of jugular venous
optical attenuation (JVA) and central venous pressure (CVP)
during a 15 s Valsalva maneuver in which the participants ex-
haled through a mouthpiece connected to a pressure transducer
to achieve an intrathoracic pressure increase of 40 mmHg.
Ultrasound images show the internal jugular vein in supine
rest and at peak Valsalva pressure. See Supplementary Video 1
for the full animation.
D. Impaired Cardiac Filling
Venous return was experimentally impeded through a Val-
salva maneuver. Fig. 5 shows a representative example of the
effect of Valsalva on JVA and CVP signals. Following normal
baseline respiration, Valsalva strain resulted in an increase in
intrathoracic pressure causing an increase in external pressure
on the heart and thoracic blood vessels. Compression of
the superior vena cava impedes venous return and results
in distended IJV and increases in superior vena cava and
central venous pressures [35]. This duality was demonstrated
by significantly lower SV at peak (43±19 mL) compared to
baseline (84±20 mL), from reduced venous return, and sig-
nificantly higher CVP at peak (29.0±11.6 cmH2O) compared
to baseline (11.7±4.3 cmH2O; see Table I and Fig. 4). A
similar significant increase in JVA was observed from baseline
(0.71±0.23 a.u.) to peak (0.78±0.22 a.u.), consistent with
jugular venous distension. Both CVP and JVA increased pro-
gressively with continued fluid congestion until strain release,
and exhibited marginally higher levels than baseline during
recovery (CVP: 13.1 vs. 11.7 cmH2O; JVA: 0.74 vs. 0.71 a.u.).
JVA exhibited strong positive linear correlation (median, in-
terquartile range) to CVP during the baseline-peak-recovery
phases (r=0.94, [0.85, 0.99]).
V. DISCUSSION
In this work, we proposed a non-contact, sub-surface op-
tical imaging system to monitor changes in jugular venous
dynamics. We have shown that JVA closely tracks induced
increases and decreases in CVP during hemodynamic stresses
induced by LBNP, HDT and Valsalva. Three physiological
protocols were designed to test multiple mechanisms of CVP
modulation: (1) reducing venous return through LBNP; and (2)
increasing venous pressure through venous congestion in HDT;
and (3) restricting venous return by increasing intrathoracic
pressure with a Valsalva maneuver. Taken together, the span of
effects of these three protocols have clinical and physiological
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significance, as discussed below. These observations support
the hypothesis that pressure-induced changes in jugular venous
size can be monitored in a non-contact way through calibrated
optical hemodynamic imaging. The current clinical standard
for monitoring CVP involves invasive right heart catheteriza-
tion [36], which limits the scope of monitoring primarily to
advanced stage cases [37]. Non-invasive optical imaging of
the jugular venous response to pressure changes would enable
a wider range of monitoring applications, both clinically and
physiologically.
Non-contact optical imaging methods for extracting hemo-
dynamic signals, or summary measures such as heart rate, are
relatively new technologies that have been gaining increased
interest in the literature [20]. Instrumentation varies between
studies, but many comprise some combination of a camera
with or without a controlled light source. Relying on the same
optical theory as finger photoplethysmography, these systems
produce unitless measurements, and thus are not suitable for
longitudinal comparison in their basic form. Diffuse optical
imaging and spectroscopy methods are able to quantify ab-
sorption per unit length of tissue through calibration pro-
cedures [27], [38], but are typically restricted in geometry
and assumptions about tissue homogeneity. We combined
the two approaches to yield a calibrated non-contact optical
imaging method for comparing changes in optical attenuation
from venous dilation by effectively determining the per-pixel
incident illumination by normalizing inhomogeneities in the
optical system and resulting from the surface profile.
LBNP causes a translocation of central blood volume to
the lower body vascular compartments without altering grav-
itational or muscular loading effects, and is an experimen-
tal model for cardiovascular response to orthostatic stress
and acute hemorrhage [39], [10]. Our experimental design
simulated the equivalent of approximately 500–1000 mL of
blood loss across the chosen pressure levels [40]. This central
hypovolemia reduced venous return leading to activation of
cardiopulmonary baroreceptors and reduction in stroke volume
that reduces arterial pulse pressure causing elevated heart
rate, sympathoexcitation and release of arginine vasopressin
to reflexively maintain arterial and cerebral perfusion pres-
sures [41]. Our data tracked the effects of greater LBNP with
reduced CVP and commensurate JVA. In some participants,
CVP was close to zero during the last stage of LBNP. MAP
remained unchanged after 4 min of exposure to each level,
indicating an effective cardiovascular response of vasocon-
striction and increased heart rate. Monitoring arterial pressure
may lead to missed early biomarkers of shock [42], whereas
venous pressures may be more indicative of early signs of
hypovolemia [10]. Thus, optical monitoring of jugular venous
changes may enable enhanced monitoring in trauma.
Venous congestion and stasis during spaceflight results from
the removal of the gravitational force which modulates venous
return. In comparison to on Earth, a cephalad fluid shift moves
venous blood away from the lower limbs toward the heart
and head, and has been associated with increased intracranial
pressure and jugular vein thrombosis in space [8], [9]. HDT
has been extensively used as an Earth-based analog to study
cardiovascular responses to spaceflight, with 6° being widely
used as a model of 0 G [43]. The resulting jugular distension
can be visually seen on astronauts aboard the International
Space Station, and is consistent with increases in JVA ob-
served in this study. Exposure to 24 h simulated spaceflight
microgravity has shown that intracranial pressure levels are
chronically elevated above those observed during 90° seated
position on Earth [8], which has implications in ocular re-
modeling in space [7]. A mismatch between intracranial and
intraocular pressure is one of the primary hypotheses behind
visual acuity impairments in space [44]. Non-intrusive contin-
uous measurements of jugular venous volume and waveform
over an entire mission may enable identification of abnormal
responses to spaceflight, or evaluation of the effectiveness of
countermeasures designed to limit the severity of spaceflight
associated neuro-ocular syndrome.
Restricted venous return is present is right heart failure,
where inefficient cardiac function leads to fluid overload. In
congestive heart failure, reduced cardiac function results in
central fluid accumulation with elevated CVP. Jugular venous
distension is associated with prognosis of hospitalization and
disease progression in heart failure [45]. Thus, a large em-
phasis is placed on managing, and therefore monitoring, fluid
levels [46]. Since jugular venous distension correlates well to
right atrial pressure and left ventricular filling pressures [47],
[15], we used a Valsalva maneuver to systematically increase
intrathoracic and cardiac pressures. Changes in jugular ve-
nous diameter through ultrasound assessment are a positive
predictor of heart failure status due largely to elevated right
atrial pressure [15], [14]. In our healthy participant sample,
we observed significant changes in JVA during the Valsalva
strain compared to baseline, indicating a measured difference
in jugular distension, and suggesting that it may be a clinically
relevant non-contact alternative for heart failure monitoring.
The primary limitation of this work is the assumption that
all other physiological and environmental systems remain
constant across conditions, and that the change in optical
attenuation was solely due to changes in blood volume. This
was achieved by performing the three protocols in a single
data collection session, where environmental and physiological
conditions could be controlled. However, during longitudinal
monitoring, additional factors that could alter tissue optical
properties must be explicitly modeled, such as blood oxygen
saturation, hematocrit, and skin blood volume. We also ac-
knowledge that CVP was used to validate observed changes
in JVA, which is a measurement of blood volume in the vein,
and could be influenced by venous compliance. Exceptionally
high pressures may result in a reduced volume response. Thus,
the generalizability of these results to changes in already high
venous pressures as well as changes in venous tone requires
further research with affected populations.
VI. CONCLUSION
In this paper, we proposed a non-contact optical imag-
ing system for assessing changes in jugular venous optical
attenuation resulting from altered central venous pressure.
Comparison of optical attenuation of the jugular vein in dif-
ferent imaging configurations was performed using a proposed
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surface profile calibration and signal denoising pipeline. Using
a time-synchronized arterial waveform, the jugular venous
waveform was extracted and compared in three physiological
protocols: central hypovolemia, venous congestion, and im-
paired cardiac filling. Results showed that changes in jugular
venous optical attenuation strongly correlated with changes
in central venous pressure, as well as reduced stroke volume
during central hypovolemia. These results suggest that non-
contact optical imaging can be used for assessing clinically
relevant hemodynamic conditions without the need for invasive
catheterization.
REFERENCES
[1] A. C. Guyton, “Determination of cardiac output by equating venous
return curves with cardiac response curves,” Physiological Reviews,
vol. 35, no. 1, pp. 123–129, 1955.
[2] M. Dupont, W. Mullens, and W. W. Tang, “Impact of systemic venous
congestion in heart failure,” Current Heart Failure Reports, vol. 8, no.
233, 2011.
[3] P. Holmlund, A. Eklund, L.-O. Koskinen, E. Johansson, N. Sundstro¨m,
J. Malm, and S. Qvarlander, “Venous collapse regulates intracranial
pressure in upright body positions,” American Journal of Physiology-
Regulatory, Integrative and Comparative Physiology, vol. 314, no. 3,
pp. R377–R385, 2018.
[4] C. W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. E. Casey, M. H.
Drazner, G. C. Fonarow, S. A. Geraci, T. Horwich, J. L. Januzzi et al.,
“2013 ACCF/AHA guideline for the management of heart failure: a
report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines,” Journal of the
American College of Cardiology, vol. 62, no. 16, pp. e147–e239, 2013.
[5] A. Thandra, B. Jun, and M. Chuquilin, “Papilloedema and increased
intracranial pressure as a result of unilateral jugular vein thrombosis,”
Neuro-Ophthalmology, vol. 39, no. 4, pp. 179–182, 2015.
[6] D. Zhou, R. Meng, X. Zhang, L. Guo, S. Li, W. Wu, J. Duan, H. Song,
Y. Ding, and X. Ji, “Intracranial hypertension induced by internal
jugular vein stenosis can be resolved by stenting,” European Journal
of Neurology, vol. 25, no. 2, pp. 365–372, 2018.
[7] L.-F. Zhang and A. R. Hargens, “Spaceflight-induced intracranial hyper-
tension and visual impairment: pathophysiology and countermeasures,”
Physiological Reviews, vol. 98, no. 1, pp. 59–87, 2018.
[8] J. S. Lawley, L. G. Petersen, E. J. Howden, S. Sarma, W. K. Cornwell,
R. Zhang, L. A. Whitworth, M. A. Williams, and B. D. Levine, “Effect
of gravity and microgravity on intracranial pressure,” The Journal of
Physiology, vol. 595, no. 6, pp. 2115–2127, 2017.
[9] K. Marshall-Goebel, S. S. Laurie, I. V. Alferova, P. Arbeille, S. M.
Aun˜o´n-Chancellor, D. J. Ebert, S. M. Lee, B. R. Macias, D. S. Martin,
J. M. Pattarini et al., “Assessment of jugular venous blood flow stasis
and thrombosis during spaceflight,” JAMA Network Open, vol. 2, no. 11,
p. e1915011, 2019.
[10] A. A. Alian, N. J. Galante, N. S. Stachenfeld, D. G. Silverman,
and K. H. Shelley, “Impact of lower body negative pressure induced
hypovolemia on peripheral venous pressure waveform parameters in
healthy volunteers,” Physiological Measurement, vol. 35, no. 7, p. 1509,
2014.
[11] J. T. Thibodeau and M. H. Drazner, “The role of the clinical examination
in patients with heart failure,” JACC: Heart Failure, vol. 6, no. 7, pp.
543–551, 2018.
[12] A. G. Vinayak, J. Levitt, B. Gehlbach, A. S. Pohlman, J. B. Hall, and J. P.
Kress, “Usefulness of the external jugular vein examination in detecting
abnormal central venous pressure in critically ill patients,” Archives of
Internal Medicine, vol. 166, no. 19, pp. 2132–2137, 2006.
[13] J. M. Brennan, J. E. Blair, S. Goonewardena, A. Ronan, D. Shah,
S. Vasaiwala, E. Brooks, A. Levy, J. N. Kirkpatrick, and K. T. Spencer,
“A comparison by medicine residents of physical examination versus
hand-carried ultrasound for estimation of right atrial pressure,” American
Journal of Cardiology, vol. 99, no. 11, pp. 1614–1616, 2007.
[14] P. Pellicori, A. Kallvikbacka-Bennett, R. Dierckx, J. Zhang, P. Putzu,
J. Cuthbert, V. Boyalla, A. Shoaib, A. L. Clark, and J. G. Cleland, “Prog-
nostic significance of ultrasound-assessed jugular vein distensibility in
heart failure,” Heart, vol. 101, no. 14, pp. 1149–1158, 2015.
[15] M. A. Simon, R. G. Schnatz, J. D. Romeo, and J. J. Pacella, “Bedside
ultrasound assessment of jugular venous compliance as a potential point-
of-care method to predict acute decompensated heart failure 30-day
readmission,” Journal of the American Heart Association, vol. 7, no. 15,
p. e008184, 2018.
[16] A. D. DeVore, J. Wosik, and A. F. Hernandez, “The future of wearables
in heart failure patients,” JACC: Heart Failure, vol. 7, no. 11, pp. 922–
932, 2019.
[17] A. Moc¸o, P. Hamelmann, S. Stuijk, and G. de Haan, “The importance of
posture and skin-site selection on remote measurements of neck pulsa-
tions: An ultrasonographic study,” in 2018 International Conference of
the IEEE Engineering in Medicine and Biology Society (EMBC), 2018,
pp. 5918–5921.
[18] E. J. Lam Po Tang, A. HajiRassouliha, M. P. Nash, P. M. Nielsen,
A. J. Taberner, and Y. O. Cakmak, “Non-contact quantification of jugular
venous pulse waveforms from skin displacements,” Scientific Reports,
vol. 8, p. 17236, 2018.
[19] F. Abnousi, G. Kang, J. Giacomini, A. Yeung, S. Zarafshar, N. Vesom,
E. Ashley, R. Harrington, and C. Yong, “A novel noninvasive method
for remote heart failure monitoring: the EuleriAn video Magnification
apPLications In heart Failure studY (AMPLIFY),” npj Digital Medicine,
vol. 2, p. 80, 2019.
[20] Y. Sun and N. Thakor, “Photoplethysmography revisited: from contact to
noncontact, from point to imaging,” IEEE Transactions on Biomedical
Engineering, vol. 63, no. 3, pp. 463–477, 2015.
[21] S. L. Jacques, “Optical properties of biological tissues: a review,”
Physics in Medicine & Biology, vol. 58, no. 11, p. R37, 2013.
[22] I. Garcı´a-Lo´pez and E. Rodriguez-Villegas, “Extracting the jugular ve-
nous pulse from anterior neck contact photoplethysmography,” Scientific
Reports, vol. 10, p. 3466, 2020.
[23] R. Amelard, R. L. Hughson, D. K. Greaves, K. J. Pfisterer, J. Leung,
D. A. Clausi, and A. Wong, “Non-contact hemodynamic imaging reveals
the jugular venous pulse waveform,” Scientific Reports, vol. 7, p. 40150,
2017.
[24] D. T. Delpy, M. Cope, P. van der Zee, S. Arridge, S. Wray, and J. Wyatt,
“Estimation of optical pathlength through tissue from direct time of
flight measurement,” Physics in Medicine & Biology, vol. 33, no. 12,
pp. 1433–1442, 1988.
[25] F. Scholkmann, S. Kleiser, A. J. Metz, R. Zimmermann, J. M. Pavia,
U. Wolf, and M. Wolf, “A review on continuous wave functional near-
infrared spectroscopy and imaging instrumentation and methodology,”
NeuroImage, vol. 85, pp. 6–27, 2014.
[26] K. H. Shelley, “Photoplethysmography: beyond the calculation of arterial
oxygen saturation and heart rate,” Anesthesia & Analgesia, vol. 105,
no. 6, pp. S31–S36, 2007.
[27] D. J. Cuccia, F. P. Bevilacqua, A. J. Durkin, F. R. Ayers, and B. J.
Tromberg, “Quantitation and mapping of tissue optical properties using
modulated imaging,” Journal of Biomedical Optics, vol. 14, no. 2, p.
024012, 2009.
[28] R. Amelard, C. Scharfenberger, F. Kazemzadeh, K. J. Pfisterer, B. S.
Lin, D. A. Clausi, and A. Wong, “Feasibility of long-distance heart
rate monitoring using transmittance photoplethysmographic imaging
(PPGI),” Scientific Reports, vol. 5, p. 14637, 2015.
[29] R. Amelard, D. A. Clausi, and A. Wong, “Spatial probabilistic pulsatility
model for enhancing photoplethysmographic imaging systems,” Journal
of Biomedical Optics, vol. 21, no. 11, p. 116010, 2016.
[30] O. H. Gauer and H. O. Sieker, “The continuous recording of central
venous pressure changes from an arm vein,” Circulation Research, vol. 4,
no. 1, pp. 74–78, 1956.
[31] A. V. Moco, S. Stuijk, and G. De Haan, “Ballistocardiographic arti-
facts in PPG imaging,” IEEE Transactions on Biomedical Engineering,
vol. 63, no. 9, pp. 1804–1811, 2015.
[32] D. S. Martin, S. M. Lee, T. P. Matz, C. M. Westby, J. M. Scott, M. B.
Stenger, and S. H. Platts, “Internal jugular pressure increases during
parabolic flight,” Physiological Reports, vol. 4, no. 24, p. e13068, 2016.
[33] B. R. Macias, J. H. Liu, C. Otto, and A. R. Hargens, Intracranial
Pressure and its Effect on Vision in Space and on Earth. World
Scientific, 2017.
[34] J. F. Henriques, R. Caseiro, P. Martins, and J. Batista, “High-speed
tracking with kernelized correlation filters,” IEEE Transactions on
Pattern Analysis and Machine Intelligence, vol. 37, no. 3, pp. 583–596,
2014.
[35] M. J. Attubato, E. S. Katz, F. Feit, N. Bernstein, D. Schwartzman, and
I. Kronzon, “Venous changes occurring during the Valsalva maneuver:
evaluation by intravascular ultrasound,” The American Journal of Car-
diology, vol. 74, no. 4, pp. 408–410, 1994.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. XX, NO. XX, XXXXXX 9
[36] G. C. Wong, S. van Diepen, C. Ainsworth, R. C. Arora, J. G. Diodati,
M. Liszkowski, M. Love, C. Overgaard, G. Schnell, J.-F. Tanguay
et al., “Canadian Cardiovascular Society/Canadian Cardiovascular Criti-
cal Care Society/Canadian Association of Interventional Cardiology po-
sition statement on the optimal care of the postarrest patient,” Canadian
Journal of Cardiology, vol. 33, no. 1, pp. 1–16, 2017.
[37] S. Tibby and I. Murdoch, “Monitoring cardiac function in intensive
care,” Archives of Disease in Childhood, vol. 88, no. 1, pp. 46–52, 2003.
[38] F. Bevilacqua, A. J. Berger, A. E. Cerussi, D. Jakubowski, and B. J.
Tromberg, “Broadband absorption spectroscopy in turbid media by
combined frequency-domain and steady-state methods,” Applied Optics,
vol. 39, no. 34, pp. 6498–6507, 2000.
[39] W. H. Cooke, K. L. Ryan, and V. A. Convertino, “Lower body negative
pressure as a model to study progression to acute hemorrhagic shock in
humans,” Journal of Applied Physiology, vol. 96, no. 4, pp. 1249–1261,
2004.
[40] J. Hanson, R. Van Hoeyweghen, E. Kirkman, A. Thomas, and M. Horan,
“Use of stroke distance in the early detection of simulated blood loss,”
Journal of Trauma and Acute Care Surgery, vol. 44, no. 1, pp. 128–134,
1998.
[41] P. Norsk, P. Ellegaard, R. Videbaek, C. Stadeager, F. Jessen, L. Johansen,
M. Kristensen, M. Kamegai, J. Warberg, and N. J. Christensen, “Arterial
pulse pressure and vasopressin release in humans during lower body neg-
ative pressure,” American Journal of Physiology-Regulatory, Integrative
and Comparative Physiology, vol. 264, no. 5, pp. R1024–R1030, 1993.
[42] M. Wilson, D. P. Davis, and R. Coimbra, “Diagnosis and monitoring
of hemorrhagic shock during the initial resuscitation of multiple trauma
patients: a review,” The Journal of Emergency Medicine, vol. 24, no. 4,
pp. 413–422, 2003.
[43] A. R. Hargens and L. Vico, “Long-duration bed rest as an analog to
microgravity,” Journal of applied physiology, vol. 120, no. 8, pp. 891–
903, 2016.
[44] T. H. Mader, C. R. Gibson, A. F. Pass, L. A. Kramer, A. G. Lee,
J. Fogarty, W. J. Tarver, J. P. Dervay, D. R. Hamilton, A. Sargsyan et al.,
“Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts
observed in astronauts after long-duration space flight,” Ophthalmology,
vol. 118, no. 10, pp. 2058–2069, 2011.
[45] M. H. Drazner, J. E. Rame, L. W. Stevenson, and D. L. Dries,
“Prognostic importance of elevated jugular venous pressure and a third
heart sound in patients with heart failure,” New England Journal of
Medicine, vol. 345, no. 8, pp. 574–581, 2001.
[46] S. Gelman and L. Bigatello, “The physiologic basis for goal-directed
hemodynamic and fluid therapy: the pivotal role of the venous circu-
lation,” Canadian Journal of Anesthesia, vol. 65, no. 3, pp. 294–308,
2018.
[47] R. Davison and R. Cannon, “Estimation of central venous pressure by
examination of jugular veins,” American Heart Journal, vol. 87, no. 3,
pp. 279–282, 1974.
